Flame Biosciences logo

Flame Biosciences

A clinical-stage pioneer focused on discovering, developing, and commercializing groundbreaking therapies for cancer and inflammatory diseases.

1 employees · est. 2017

VS
Opus Genetics logo

Opus Genetics

Gene therapy company for inherited retinal diseases

42 employees · est. 2021 · Raleigh, United States

Flame Biosciences is the older company (2017 vs 2021); Opus Genetics is the larger of the two.

Side-by-Side Comparison

Flame Biosciences Opus Genetics
Founded
2017 older 2021
Headquarters
Not tracked yet Raleigh, United States
Employees
1 42 larger
Industry
Biotechnology, Health Care Health Care, Health and Wellness
Funding Stage
Series Unknown Grant
Total Funding
$100.00M $20.70M
Funding Rounds
1 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical-stage, Therapeutics, Cancer, Inflammatory Diseases, Drug Development, Clinical Trials, Precision Medicine Gene Therapy, Inherited Retinal Diseases, Clinical-stage, Patient-first Approach, Opthamology, Start-up, Investor-backed, Foundation Fighting Blindness, RD Fund, Orphan Diseases
Website
flame.bio opusgtx.com
Flame Biosciences logo

About Flame Biosciences

Flame Biosciences is a clinical-stage pioneer in the biotechnology and healthcare industries, focusing on the discovery, development, and commercialization of groundbreaking therapies for cancer and inflammatory diseases. Established in 2017, the company has garnered significant attention with its r...

Opus Genetics logo

About Opus Genetics

Opus Genetics is a pioneering clinical-stage gene therapy company focused on orphan inherited retinal diseases, aiming to put patients at the forefront of their mission. Established in 2004, the company operates in the Health Care industry and is headquartered in the United States. Opus Genetics has...

We will tell you when either one moves

BounceWatch watches Flame Biosciences and Opus Genetics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Flame Biosciences and Opus Genetics — by email.

Frequently Asked Questions

Flame Biosciences — A clinical-stage pioneer focused on discovering, developing, and commercializing groundbreaking therapies for cancer and inflammatory diseases.. Opus Genetics — Gene therapy company for inherited retinal diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Flame Biosciences has raised $100.00M while Opus Genetics has raised $20.70M.
Flame Biosciences and Opus Genetics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Flame Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Flame Biosciences on 11 Sep 2024, and Opus Genetics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy